SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-15-007651
Filing Date
2015-01-29
Accepted
2015-01-29 20:23:01
Documents
2
Period of Report
2015-01-29

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2230
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4652
  Complete submission text file 0001209191-15-007651.txt   8285
Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address
Betz Alert Lorris (Reporting) CIK: 0001631393 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36819 | Film No.: 15560553